HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Kersemans Selected Research

Phenylalanine (L-Phenylalanine)

1/2019New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
4/2010Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
7/2007D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.
1/2006Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
12/2005In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
3/2005In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Kersemans Research Topics

Disease

10Neoplasms (Cancer)
11/2021 - 03/2005
5Prostatic Neoplasms (Prostate Cancer)
11/2022 - 12/2019
5Rhabdomyosarcoma
04/2010 - 03/2005
2Glioblastoma (Glioblastoma Multiforme)
05/2019 - 01/2019
2Inflammation (Inflammations)
12/2005 - 03/2005
1Body Weight (Weight, Body)
12/2019
1Brain Neoplasms (Brain Tumor)
01/2019
1Hypoxia (Hypoxemia)
03/2018
1Adenocarcinoma
03/2018
1Liver Diseases (Liver Disease)
01/2018
1Cholestasis
01/2017
1Cognitive Dysfunction
03/2010
1Memory Disorders (Memory Loss)
03/2010
1Glioma (Gliomas)
07/2007

Drug/Important Bio-Agent (IBA)

6Phenylalanine (L-Phenylalanine)FDA Link
01/2019 - 03/2005
5(18)F-PSMA-11IBA
11/2022 - 12/2019
4Tyrosine (L-Tyrosine)FDA Link
01/2019 - 01/2006
4Amino AcidsFDA Link
08/2006 - 12/2005
3gallium 68 PSMA-11IBA
11/2022 - 12/2019
2Radioisotopes (Radionuclides)IBA
11/2021 - 04/2010
2fluoroazomycin arabinosideIBA
05/2019 - 03/2018
2Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2019 - 12/2005
2Bile Acids and Salts (Bile Acids)IBA
01/2018 - 01/2017
2PropionatesIBA
08/2006 - 01/2006
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2005 - 03/2005
1AntigensIBA
12/2019
1salicylhydroxamic acid (SHAM)IBA
05/2019
1Radiation-Sensitizing AgentsIBA
03/2018
1NimorazoleIBA
03/2018
1AcidsIBA
01/2017
1Firefly LuciferasesIBA
04/2010
1valylvaline (Val-Val)IBA
03/2010
1des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
03/2010
12-iodotyrosineIBA
07/2007
1Serum AlbuminIBA
03/2005
1Theophylline (Theon)FDA LinkGeneric
03/2005

Therapy/Procedure

2Therapeutics
11/2021 - 05/2019
2Radiotherapy
05/2019 - 03/2018
1PET protocol
02/2020